Veritas Pharma Stock Today
| VRTHF Stock | USD 0 0.00 0.00% |
Performance0 of 100
| Odds Of DistressOver 67
|
Veritas Pharma is trading at 0.0015 as of the 1st of December 2024. This is a No Change since the beginning of the trading day. The stock's lowest day price was 0.0015. Veritas Pharma has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Veritas Pharma are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Indigenous Bloom Hemp Corp. focuses on the production of hemp products for commercial use. It sells hemp biomass and flowers, as well as phytocannabinoid rich extracts derived from hemp biomass. Indigenous Bloom is traded on OTC Exchange in the United States. The company has 71.14 M outstanding shares. More on Veritas Pharma
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Veritas Pink Sheet Highlights
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Veritas Pharma [VRTHF] is a Pink Sheet which is traded between independent brokers as part of over-the-counter (OTC) trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 1.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Veritas Pharma's market, we take the total number of its shares issued and multiply it by Veritas Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Veritas Pharma classifies itself under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 71.14 M outstanding shares.
Veritas Pharma has accumulated about 125.27 K in cash with (294.86 K) of positive cash flow from operations.
Check Veritas Pharma Probability Of Bankruptcy
Ownership AllocationVeritas Pharma shows a total of 71.14 Million outstanding shares. Veritas Pharma maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Veritas Ownership Details
Veritas Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Veritas Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
| All Next | Launch Module |
Other Information on Investing in Veritas Pink Sheet
Veritas Pharma financial ratios help investors to determine whether Veritas Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Veritas with respect to the benefits of owning Veritas Pharma security.